4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period for schizophrenia
This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period for schizophrenia.
SchizophreniaDrugFrom 18 Years to 50 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether BI 425809 Effect on Cognition and Functional Capacity may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive BI 425809 Effect on Cognition and Functional Capacity, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Austria, in Canada, and in Germany.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: July 25, 2016
Recruitment status
Completed
Enrollment listed in the registry
509
Sponsor
Boehringer Ingelheim
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada, United Kingdom, ...
Age range
From 18 Years to 50 Years
Official registry ID
NCT02832037
Official title
A Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT02832037. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Austria · 2 sites
Medical University of Innsbruck
Innsbruck
Site status: Not listed — confirm with the team
AKH - Medical University of Vienna
Vienna
Site status: Not listed — confirm with the team
Canada · 5 sites
Dr. Alexander McIntyre Inc.
Penticton, British Columbia
Site status: Not listed — confirm with the team
The Medical Arts Health Research Group
Vancouver, British Columbia
Site status: Not listed — confirm with the team
Chatham-Kent Clinical Trials Research Centre
Chatham, Ontario
Site status: Not listed — confirm with the team
Centre for Addiction and Mental Health (CAMH)
Toronto, Ontario
Site status: Not listed — confirm with the team
IUSMM Institut Universitaire en Sante Mentale de Montreal
Montreal, Quebec
Site status: Not listed — confirm with the team
Germany · 7 sites
Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen
Bad Homburg
Site status: Not listed — confirm with the team
Praxis Dr. Volker Schumann
Berlin
Site status: Not listed — confirm with the team
Berufsausübungsgemeinschaft, Dr. sc. med. Alexander Schulze und Prof. Dr. med. Hagen Kunte
Berlin
Site status: Not listed — confirm with the team
Praxis Dr. Hahn, Berlin
Berlin
Site status: Not listed — confirm with the team
PANAKEIA Arzneimittelforschung Leipzig GmbH
Leipzig
Site status: Not listed — confirm with the team
Zentralinstitut für seelische Gesundheit
Mannheim
Site status: Not listed — confirm with the team
Neurologie und Psychiatrie / Psychotherapie
Westerstede
Site status: Not listed — confirm with the team
Italy · 3 sites
ASST degli Spedali Civili di Brescia
Concesio (BS)
Site status: Not listed — confirm with the team
Asst Santi Paolo E Carlo
Milan
Site status: Not listed — confirm with the team
Azienda Sanitaria Ospedale S. Luigi Gonzaga
Orbassano (TO)
Site status: Not listed — confirm with the team
Japan · 14 sites
Fujita Health University Hospital
Aichi, Toyoake
Site status: Not listed — confirm with the team
Chiba University Hospital
Chiba, Chiba
Site status: Not listed — confirm with the team
National Center for Global Health and Medicine Kohnodai Hospital
Chiba, Ichikawa
Site status: Not listed — confirm with the team
Hospital of the University of Occupational and Environmental Health
Fukuoka, Kitakyushu
Site status: Not listed — confirm with the team
Hokkaido University Hospital
Hokkaido, Sapporo
Site status: Not listed — confirm with the team
Kobe University Hospital
Hyogo, Kobe
Site status: Not listed — confirm with the team
Kagawa University Hospital
Kagawa, Kita-gun
Site status: Not listed — confirm with the team
Kishiro Mental Clinic
Kanagawa, Kawasaki
Site status: Not listed — confirm with the team
Nara Medical University Hospital
Nara, Kashihara
Site status: Not listed — confirm with the team
Kansai Medical University Medical Center
Osaka, Moriguchi
Site status: Not listed — confirm with the team
Iwaki Clinic, Tokushima, Psychosomatic Medicine
Tokushima, Anan
Site status: Not listed — confirm with the team
National Center Neurology and Psychiatry
Tokyo, Kodaira
Site status: Not listed — confirm with the team
Showa University Karasuyama Hospital
Tokyo, Setagaya
Site status: Not listed — confirm with the team
Tokyo Women's Medical University Hospital
Tokyo, Shinjuku-ku
Site status: Not listed — confirm with the team
Poland · 7 sites
Wlokiennicza Med,Spec.Med.Prac,MD Tomasz Markowski,Bialystok
Bialystok
Site status: Not listed — confirm with the team
Podlassian Center of Psychogeriatry, Bialystok
Bialystok
Site status: Not listed — confirm with the team
Osrodek Badan Klinicznych CLINSANTE S.C.
Bydgoszcz
Site status: Not listed — confirm with the team
Non-public Health Care Psychiatric Institution MENTIS,Leszno
Leszno
Site status: Not listed — confirm with the team
EUROMEDIS Sp. z o.o., Szczecin
Szczecin
Site status: Not listed — confirm with the team
Clin.Research Centre Clinsante SC Ewa Galczak-Nowak,Torun
Torun
Site status: Not listed — confirm with the team
Therapy Centre DIALOG Sp.z o.o. S.j.
Warsaw
Site status: Not listed — confirm with the team
South Korea · 7 sites
Chonnam National University Hospital
Gwangju
Site status: Not listed — confirm with the team
Gachon University Gil Medical Center
Incheon
Site status: Not listed — confirm with the team
Seoul National University Bundang Hospital
Seongnam
Site status: Not listed — confirm with the team
Seoul National University Hospital
Seoul
Site status: Not listed — confirm with the team
Severance Hospital
Seoul
Site status: Not listed — confirm with the team
National Center for Mental Health
Seoul
Site status: Not listed — confirm with the team
Asan Medical Center
Seoul
Site status: Not listed — confirm with the team
Spain · 6 sites
Hospital del Mar
Barcelona
Site status: Not listed — confirm with the team
Centro de Salud Mental de Fuencarral
Madrid
Site status: Not listed — confirm with the team
Fundación Jiménez Díaz
Madrid
Site status: Not listed — confirm with the team
Hospital Puerta de Hierro
Majadahonda (Madrid)
Site status: Not listed — confirm with the team
Centro de Salud de San Juan
Salamanca
Site status: Not listed — confirm with the team
Hospital Universitario Marqués de Valdecilla
Santander
Site status: Not listed — confirm with the team
Taiwan · 4 sites
NCKUH
Tainan
Site status: Not listed — confirm with the team
National Taiwan University Hospital
Taipei
Site status: Not listed — confirm with the team
Taipei City Hospital
Taipei
Site status: Not listed — confirm with the team
Taipei Veterans General Hospital
Taipei
Site status: Not listed — confirm with the team
United Kingdom · 5 sites
Bushey Fields Hospital
Dudley
Site status: Not listed — confirm with the team
Royal Edinburgh Hospital
Edinburgh
Site status: Not listed — confirm with the team
Queen Elizabeth University Hospital
Glasgow
Site status: Not listed — confirm with the team
King's College Hospital
London
Site status: Not listed — confirm with the team
Royal Cornwall Hospital
Truro
Site status: Not listed — confirm with the team
United States · 21 sites
Collaborative Neuroscience Network, LLC (CNS)
Garden Grove, California
Site status: Not listed — confirm with the team
Synergy San Diego
Lemon Grove, California
Site status: Not listed — confirm with the team
NRC Research Institute
Orange, California
Site status: Not listed — confirm with the team
Alliance for Wellness
Panorama City, California
Site status: Not listed — confirm with the team
CNRI - Los Angeles
Pico Rivera, California
Site status: Not listed — confirm with the team
CNRI-San Diego, LLC
San Diego, California
Site status: Not listed — confirm with the team
Premier Clinical Research Institute
Miami, Florida
Site status: Not listed — confirm with the team
Synexus
Atlanta, Georgia
Site status: Not listed — confirm with the team
Atlanta Center
Atlanta, Georgia
Site status: Not listed — confirm with the team
Uptown Research Institute
Chicago, Illinois
Site status: Not listed — confirm with the team
Lake Charles Clinical Trials LLC
Lake Charles, Louisiana
Site status: Not listed — confirm with the team
Michigan Clinical Research Institute PC
Ann Arbor, Michigan
Site status: Not listed — confirm with the team
Mid-America Clinical Research, LLC
St Louis, Missouri
Site status: Not listed — confirm with the team
University at Buffalo, The State University of New York
Buffalo, New York
Site status: Not listed — confirm with the team
Neurobehavioral Research, Inc.
Cedarhurst, New York
Site status: Not listed — confirm with the team
Finger Lakes Clinical Research
Rochester, New York
Site status: Not listed — confirm with the team
North Carolina Psychiatric Research Center
Raleigh, North Carolina
Site status: Not listed — confirm with the team
Midwest Clinical Research
Dayton, Ohio
Site status: Not listed — confirm with the team
InSite Clinical Research
DeSoto, Texas
Site status: Not listed — confirm with the team
Psychiatric and Behavioral Solutions, LLC
Salt Lake City, Utah
Site status: Not listed — confirm with the team
Northwest Clinical Research Center
Bellevue, Washington
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3, BI 425809 dose 4, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
